{"entity":{"id":"kyan-technologies","kind":"company","name":"KYAN Technologies","aka":[],"tldr":"KYAN Technologies uses a small set of live-cell experiments and its own AI to rank more than 1,500 personalised drug combinations for a patient's cancer.","summary":"KYAN Technologies, based in Singapore with US operations, markets Optim.AI, a functional precision medicine platform that tests a patient's live cancer cells against drugs and uses its algorithm to evaluate and rank over 1,500 personalised combinations. Physician-ordered.","asOf":"2026-09-11","links":[{"label":"Official website","url":"https://kyantechnologies.com/"},{"label":"Listed on Future of Cancer Care Today (Sijbrandij Foundation)","url":"https://sijbrandijfoundation.org/fcct"}],"tags":["ctgov-sponsor","fcct-directory"],"related":[],"cancers":[],"sections":[],"technologies":["functional-drug-testing"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"provenance":{"editedBy":"OnCo ingestion (ClinicalTrials.gov v2 + sponsor websites)","editedOn":"2026-09-11"},"hq":"Singapore","country":"SG","companyType":"diagnostics","website":"https://kyantechnologies.com/","investors":[],"funding":[]},"route":"/companies/kyan-technologies/","neighbours":{"technology":[{"id":"functional-drug-testing","kind":"technology","name":"Functional (ex vivo) drug testing","route":"/technologies/functional-drug-testing/"}]}}